Conexeu Sciences Inc.
CNXU
NASDAQ·Healthcare·Biotechnology·Mkt cap $133.0M
$4.97
▼ -5.69%
P/E
—
Mkt Cap
$133.0M
52-Wk Range
$4.85–$18.79
52-Week Range
$4.85 - $18.79
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 62.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
No forward estimates available
Value
Valuation data unavailable
Momentum
Falling
-67.5% over 3m
Quality
Below
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying CNXU right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 30, 2026
Earnings recap unavailable for this period.
Reported EPS · last 4Q
No quarterly earnings data on file.
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Jun 22, 2026
vs Industry
How CNXU stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.